BioWorld Asia

Dec. 17, 2003

Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever

Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International) Read More

Arpida Moving Iclaprim Into Phase III Trial, Seeking EUR25M

Trial To Test Recombinant Poxvirus Vaccine In Malaria

Genmab Stops HuMax-CD4 Development In Psoriasis

Ingenium Plans Growth After Third Round Brings In EUR13.8M

Benitec Settles ddRNAi Dispute, Raises A$10.9M To Fund Growth

Faust Pharmaceuticals Acquires Euroclide, Seeks EUR12M Funding

Innate Pharma, Novo Nordisk In Cancer Immunotherapy Deal

Novacea Licenses Cancer Drug From KuDOS Pharmaceuticals

London Cluster Growing But Lab Space Shortage Impedes

EU Moving Closer To New Rules On Pharmaceuticals, Tissues, Cells

Industry Representatives Meet In Israel To Discuss Bioengineering

Fulcrum To Help Addex Build Internal Clinical Development

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...